CHEK2 and breast carcinoma: Using a 40 gene panel, another study found a non-BRCA gene mutation rate of 6.8% in a cohort of 937 Chinese breast cancer patients, with TP53 (1.9%), PALB2 (1.2%), CHEK2 (0.6%) and ATM (0.6%) being the major non-BRCA genes identified (Li et al., 2019).